To require that pharmacies, authorized health care practitioners, and registered shopkeepers and itinerant vendors selling products containing ephedrine, pseudoephedrine, or phenylpropanolamine store the products in an inaccessible place and require their customers to produce photo identification and sign a log documenting the transaction.   Official Text and Analysis.

To designate products that contain ephedrine, pseudoephedrine, or phenylpropanolamine as the only active ingredient as Schedule V controlled substances. Products that contain ephedrine, pseudoephedrine, or phenylpropanolamine in combination with another active ingredient must be stored in a location that is inaccessible to the public. Product manufacturers may petition the Board of Pharmacy to exempt products that will not produce dangerous controlled substances.

To remove the Schedule V controlled substance designation for products that contain ephedrine, pseudoephedrine, or phenylpropanolamine as the only active ingredient and requires that these products only be sold at retail by pharmacies or authorized health care providers. Places photo identification, written log, age, and access requirements on the sale of products that contain ephedrine, pseudoephedrine, or phenylpropanolamine as the only active ingredient in the same manner as combination products. Removes exemptions for liquid and gel capsule forms of products that contain ephedrine, pseudoephedrine, or phenylpropanolamine as the only active ingredient. (BLAC 065).

To allow employees of pharmacies, pharmacists, or practitioners to sell, dispense or distribute products containing ephedrine, pseudoephedrine, or phenylpropanolamine as their only active ingredient. (BLAC 073).

To require that the Board of Pharmacy inspect all written logs at least once every three months at the location where the log is maintained. Requires the Board of Pharmacy to investigate any suspicious transactions and report them to law enforcement officials. Prohibits the Department of Health from increasing the fees of regulated vendors to pay for the purposes of the act. Provides that the act is null and void if the inspection activities are not funded in the Budget Act. (BLAC 071).

To remove requirements that products containing ephedrine, pseudoephedrine, and phenylpropanolamine as their only active ingredient be sold only at pharmacies and transactions involving these products be entered in a written log. Removes identification, log, accessibility, and age requirements on the sale of products containing ephedrine, pseudoephedrine and phenylpropanolamine in combination with another active ingredient. Removes the exemption for products containing ephedrine, pseudoephedrine, and phenylpropanolamine in liquid and gel capsule forms. Authorizes the Washington Association of Sheriffs and Police Chiefs or the Washington State Patrol to petition the Board of Pharmacy to place restrictions on products containing ephedrine, pseudoephedrine and phenylpropanolamine in combination with another active ingredient when there is evidence of their use for the illegal manufacture of methamphetamine or another dangerous controlled substance. Permits the Board of Pharmacy to adopt rules to restrict products upon petition of the Washington Association of Sheriffs and Police Chiefs. Establishes criteria to remove restrictions from products. (BLAC 072).

To remove requirements that products containing ephedrine, pseudoephedrine, and phenylpropanolamine as their only active ingredient be sold only at pharmacies and transactions involving these products be entered in a written log. Exempts products containing ephedrine, pseudoephedrine, and phenylpropanolamine as their only active ingredient and that are in liquid, liquid capsule, or gel capsule from the pharmacy requirement. Removes identification, log, accessibility, and age requirements on the sale of products containing ephedrine, pseudoephedrine and phenylpropanolamine in combination with another active ingredient. Removes the exemption for products containing ephedrine, pseudoephedrine, and phenylpropanolamine in liquid and gel capsule forms. Authorizes the Washington Association of Sheriffs and Police Chiefs, the Washington State Patrol, or Department of Ecology to petition the Board of Pharmacy to place restrictions on products containing ephedrine, pseudoephedrine and phenylpropanolamine in combination with another active ingredient or as the only active ingredient when in liquid, liquid capsule, or gel capsule form when there is evidence of their use for the illegal manufacture of methamphetamine or another dangerous controlled substance. Permits the Board of Pharmacy to adopt rules to restrict products upon petition of the Washington Association of Sheriffs and Police Chiefs. Establishes criteria to remove restrictions from products. (Blac 076).

To require that products containing products containing ephedrine, pseudoephedrine, or phenylpropanolamine be in an inaccessible place .

By the Senate Judiciary Committee, to add the package size, purchase, and possession restrictions. The Washington Association of Sheriffs and Police Chiefs study is added. The statewide database is added. Electronic log and video record provisions are added. All products containing any detectible amount of ephedrine, pseudoephedrine, or phenylpropanolamine must be inaccessible without assistance.

To establish that employees who fail to request ID commit a class 3 civil infraction.

To provide that the state board of pharmacy will convene a work group to study the need for requiring and maintaining logs of transactions involving ephedrine, pseudoephedrine, or phenylpropanolamine. The work group will include representatives from law enforcement, prosecutors, Attorney General's office, state board of pharmacy, and the retail industry.

By the Senate Ways and Means Committee, to remove identification, log, accessibility, and age requirements on the sale of products containing ephedrine, pseudoephedrine, and phenylpropanolamine in combination with another active ingredient. It authorizes the Washington Association of Sheriffs and Police Chiefs or the Washington State Patrol to petition the Board of Pharmacy to place restrictions on products containing ephedrine, pseudoephedrine, and phenylpropanolamine in combination with another active ingredient when there is evidence of their use for the illegal manufacture of methamphetamine or another dangerous controlled substance. It permits the Board of Pharmacy to adopt rules to restrict products upon petition of the Washington Association of Sheriffs and Police Chiefs. It establishes criteria to remove restrictions from products.

To require that products containing products containing ephedrine, pseudoephedrine, or phenylpropanolamine be in an inaccessible place.

But the House refuses to concur on Senate amendments, and asks the Senate for a bill conference. The House appoints Reps. Morrell, Campbell, and Curtis to a conference committee.

And the conference committee request is granted. The Senate appoints Sens. Kline, Kastama, and Johnson to the bill conference committee.

To accept the conference committee's recommendations.

As reccomended by the bill conference committee.

To require that products containing products containing ephedrine, pseudoephedrine, or phenylpropanolamine be in an inaccessible place.